Pyxus International Reports 28.9% Increase in Sales for Q3

Nov.14.2022
Pyxus International Reports 28.9% Increase in Sales for Q3
Pyxus International's sales and revenue increased by 28.9% to $508.3 million in Q3 2022, with adjusted EBITDA rising 63% to $42.2 million.

Pyxus International, a multinational company, has reported a 28.9% increase in sales revenue and other operating income, totaling $508.3 million for the three months ending on September 30, 2022, as compared to the previous year. The company's operating profit margin has increased by $21.6 million, reaching $27.1 million. However, the net loss has increased by $8.2 million, reaching $1.5 million. Adjusted EBITDA has increased by 63% to $42.2 million.


We are pleased with the results achieved in the first half of the 2023 fiscal year, particularly the efforts we have made to reduce supply chain complexity and improve operational efficiency," said Pieter Sikkel, President and CEO of Pyxus, in a statement.


Compared to last year, these efforts have led to a more normalized shipment volume in certain markets. In this quarter, we saw an increase of $114.1 million in sales and other operating revenue, with a $21.6 million increase in operating profit margin, largely due to increased demand and more standardized shipping times from Africa, Asia, and South America.


This allows the company to use the cash generated from the increased sales in this quarter to refinance delayed draw term loans, repay a portion of revolving credit financing, and provide full funding for the US fixed-income pension plan.


As of September 30, 2022, our inventory has increased by $87.7 million compared to the previous year. This is mainly due to higher green tobacco prices and processing costs in Africa and South America, as well as delayed shipments from North America. Over 90% of our processed tobacco inventory is accounted for by specific customers. The overall increase in inventory and our committed levels of processed tobacco inventory enable us to meet current demand.


The prevailing La Niña weather pattern continues to have a detrimental impact on global tobacco supply. However, through efforts to accelerate purchasing activity in key markets, investments made throughout the business, and transparent dialogues with customers regarding the effects of La Niña and inflation on our operations, we have procured sufficient quantities to meet current customer demands. Despite historic levels of inflation, we have maintained our gross profit margin as a percentage of sales.


As we approach the second half of the fiscal year 2023, we are closely monitoring the market for agricultural inputs such as fertilizers and taking measures to mitigate the risk of recent supply shortages. We still anticipate sales for fiscal year 2023 to be between $1.75 billion and $1.95 billion, with adjusted EBITDA between $130 million and $160 million.


We remain focused on driving value for stakeholders as we accelerate our contribution to a net-zero future, and have recently been awarded the Gold Leaf Award for Best ESG Strategy in recognition of our efforts to promote sustainable fuel production and help reduce deforestation. We have received positive feedback from clients on our environmental, social, and governance framework, particularly on the strategic alignment with client objectives, and look forward to strengthening partnerships to build a better world together.


Statement:


This article is compiled from third-party information and is intended solely for industry exchange and learning purposes.


This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the authenticity or accuracy of the article's content. The translation of this article is intended for internal industry exchange and research purposes only.


Due to limitations in translation ability, the translated article may not accurately reflect the original text. Please refer to the original text for accuracy.


2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, and foreign statements and positions.


The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us to remove the content.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

UK Opens Applications for Vaping Products Duty and Duty Stamps Scheme From April 1
UK Opens Applications for Vaping Products Duty and Duty Stamps Scheme From April 1
HM Revenue and Customs announced that from April 1, 2026, UK vaping product manufacturers, importers and warehousekeepers can apply for approval under Vaping Products Duty (VPD) and the Vaping Duty Stamps Scheme (VDS). Under new GOV.UK guidance, Vaping Products Duty will take effect on October 1, 2026 and will apply to all vaping liquids, whether they contain nicotine or not.
Apr.02 by 2FIRSTS.ai
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Summary Ispire Technology announced a strategic joint venture with Chinese pharmaceutical company Jincheng Pharma to manufacture and commercialize nicotine pouch products. The partnership combines pharmaceutical-grade production capabilities with Ispire’s global regulatory infrastructure and distribution network as the company expands beyond vaping hardware into oral nicotine products.
Business
May.13
IVG Adds Six New Flavours to Pro Range, Expanding Line-Up to 39
IVG Adds Six New Flavours to Pro Range, Expanding Line-Up to 39
IVG has added six new flavours to its Pro range, taking the total line-up to 39 flavours. The new additions are Cola Frost, Rainbow Burst, Pineapple Tropic, Blueberry Raspberry, Strawberry Raspberry Ice and Raspberry Cherry Blueberry. All six are available only in 20mg nicotine strength, with an RRP of £10.95 for a starter kit and £7.95 for a refill pod.
Apr.21 by 2FIRSTS.ai
Special Report| War continues to shape the Ukrainian tobacco market
Special Report| War continues to shape the Ukrainian tobacco market
Four years into the war, Ukraine’s tobacco market is being reshaped by stress-driven consumption, tax pressure, youth e-cigarette use and a growing illicit segment. Surveys point to rising tobacco and nicotine product use, while higher excise duties and shadow trade are adding new complexity to the market.
Apr.17
PML Expands Its UK Smoke-Free Portfolio With LEVIA
PML Expands Its UK Smoke-Free Portfolio With LEVIA
Philip Morris Limited has launched LEVIA, a new range of zero-tobacco flavored nicotine sticks created for the IQOS ILUMA range. The product expands the company’s smoke-free portfolio in the UK and will initially be available in four variants, including Deep Mint and three capsule-based flavors. LEVIA has a recommended retail price of £5, or about $6.73, based on the European Central Bank’s April 28.
Apr.29 by 2FIRSTS.ai
European Commission Publishes Tobacco Control Framework Evaluation, Says Smoking and Tobacco-Related Deaths Have Declined
European Commission Publishes Tobacco Control Framework Evaluation, Says Smoking and Tobacco-Related Deaths Have Declined
The European Commission has published its evaluation of the EU tobacco control framework, assessing the effectiveness, efficiency and relevance of the Tobacco Products Directive and Tobacco Advertising Directive in protecting public health and ensuring the smooth functioning of the internal market.
Apr.03 by 2FIRSTS.ai